US 12,070,598 B2
Systems and methods for programming neuromodulation waveform
Goran N. Marnfeldt, Valencia, CA (US); and Michael A. Moffitt, Solon, OH (US)
Assigned to Boston Scientific Neuromodulation Corporation, Valencia, CA (US)
Filed by Boston Scientific Neuromodulation Corporation, Valencia, CA (US)
Filed on Aug. 31, 2021, as Appl. No. 17/462,714.
Application 17/462,714 is a continuation of application No. 16/556,730, filed on Aug. 30, 2019, granted, now 11,191,954.
Application 16/556,730 is a continuation of application No. 15/790,977, filed on Oct. 23, 2017, granted, now 10,441,781.
Claims priority of provisional application 62/425,855, filed on Nov. 23, 2016.
Prior Publication US 2021/0393951 A1, Dec. 23, 2021
Int. Cl. A61N 1/36 (2006.01); A61N 1/05 (2006.01); A61N 1/372 (2006.01)
CPC A61N 1/0551 (2013.01) [A61N 1/36062 (2017.08); A61N 1/36071 (2013.01); A61N 1/36114 (2013.01); A61N 1/36146 (2013.01); A61N 1/37235 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A user-interface (UI) device for remotely controlling a therapy device to deliver therapy to a patient, the UI device comprising:
a UI element configured to receive a single user input having a programmable numerical value indicative of therapy dosing; and
a controller circuit configured to:
map the single user input indicative of therapy dosing to settings of a plurality of therapy parameters; and
generate a control signal to the therapy device to initiate or adjust a therapy in accordance with the settings of the plurality of the therapy parameters.